Literature DB >> 21919701

Understanding the biology of 16 kDa antigen of Mycobacterium tuberculosis: scope in diagnosis, vaccine design and therapy.

Kaneez Fatima Siddiqui1, Mohammed Amir, Javed Naim Agrewala.   

Abstract

Heat shock proteins (HSPs) are conserved and ubiquitous house keeping entities that act as molecular chaperones, which protect the cell from damage during stress. One such HSP, the 16 kDa antigen, from Mycobacterium tuberculosis (Mtb) has received considerable attention due to its importance in tuberculosis latency and immunodominant property. In this article, we discuss about the potential role of 16 kDa antigen of Mtb in latency, its expression, regulation, and implication in host immune response. We also highlight the scope of employing 16 kDa in early diagnosis, development of vaccine and as a potential drug target.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21919701     DOI: 10.3109/1040841X.2011.606425

Source DB:  PubMed          Journal:  Crit Rev Microbiol        ISSN: 1040-841X            Impact factor:   7.624


  9 in total

1.  Prime-boost vaccination strategy with bacillus Calmette-Guérin (BCG) and liposomized alpha-crystalline protein 1 reinvigorates BCG potency.

Authors:  K F Siddiqui; M Amir; N Khan; G Rama Krishna; J A Sheikh; K Rajagopal; J N Agrewala
Journal:  Clin Exp Immunol       Date:  2015-06-03       Impact factor: 4.330

2.  A novel vaccine p846 encoding Rv3615c, Mtb10.4, and Rv2660c elicits robust immune response and alleviates lung injury induced by Mycobacterium infection.

Authors:  Hongmei Kong; Chunsheng Dong; Sidong Xiong
Journal:  Hum Vaccin Immunother       Date:  2013-11-26       Impact factor: 3.452

3.  Prime-boost with Mycobacterium smegmatis recombinant vaccine improves protection in mice infected with Mycobacterium tuberculosis.

Authors:  Ana Paula Junqueira-Kipnis; Fábio Muniz de Oliveira; Monalisa Martins Trentini; Sangeeta Tiwari; Bing Chen; Danilo Pires Resende; Bruna D S Silva; Mei Chen; Lydia Tesfa; William R Jacobs; André Kipnis
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

4.  Diametric Role of the Latency-Associated Protein Acr1 of Mycobacterium tuberculosis in Modulating the Functionality of Pre- and Post-maturational Stages of Dendritic Cells.

Authors:  Mohammed Amir; Mohammad Aqdas; Sajid Nadeem; Kaneez F Siddiqui; Nargis Khan; Javaid A Sheikh; Javed N Agrewala
Journal:  Front Immunol       Date:  2017-05-30       Impact factor: 7.561

5.  Mycobacterium tuberculosis host cell interaction: Role of latency associated protein Acr-1 in differential modulation of macrophages.

Authors:  Nida Mubin; Susanta Pahari; Mohammad Owais; Swaleha Zubair
Journal:  PLoS One       Date:  2018-11-05       Impact factor: 3.240

6.  Heterologous Expression, Purification, and Characterization of the HspX, Ppe44, and EsxV Proteins of Mycobacterium tuberculosis.

Authors:  Yousef Amini; Mohsen Tafaghodi; Saeid Amel Jamehdar; Zahra Meshkat; Bagher Moradi; Mojtaba Sankian
Journal:  Rep Biochem Mol Biol       Date:  2018-04

7.  ESAT-6 and HspX improve the effectiveness of BCG to induce human dendritic cells-dependent Th1 and NK cells activation.

Authors:  Laura Marongiu; Marta Donini; Lara Toffali; Elena Zenaro; Stefano Dusi
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

8.  Cytokine and Antibody Based Diagnostic Algorithms for Sputum Culture-Positive Pulmonary Tuberculosis.

Authors:  Tao Chen; Jinfei Lin; Wei Wang; Joy Fleming; Liang Chen; Yunxia Wang; Haicheng Li; Huixin Guo; Jie Zhou; Xunxun Chen; Yuhui Chen; Qinghua Liao; Yang Shu; Yaoju Tan; Meiling Yu; Guozhou Li; Lin Zhou; Qiu Zhong; Lijun Bi; Lina Guo; Meigui Zhao
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

9.  Proteomics Analysis of Three Different Strains of Mycobacterium tuberculosis under In vitro Hypoxia and Evaluation of Hypoxia Associated Antigen's Specific Memory T Cells in Healthy Household Contacts.

Authors:  Santhi Devasundaram; Akilandeswari Gopalan; Sulochana D Das; Alamelu Raja
Journal:  Front Microbiol       Date:  2016-09-09       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.